ARTV Artiva Biotherapeutics
- 12.010
- +0.240+2.04%
- 12.400
- +0.390+3.25%
Artiva Biotherapeutics News
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner venBio Global Strategic Fund III, L.P.
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner GC Corp.
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Huh Yong-Jun
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aslan Fred
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-10% Owner venBio Global Strategic Fund III, L.P.
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-10% Owner 5AM Partners VI, LLC
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director Miralles Gines Diego
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-10% Owner Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director Stoppel Laura
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director HOUGEN ELIZABETH L
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-10% Owner GC Corp.
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director DANIELS BRIAN
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Officer Raymon Heather
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director Huh Yong-Jun
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director Bessen Laura
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Officer Graef Thorsten
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Officer Krishnamohan Neha
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Officer Horan Christopher
Analysis
Price Target
No Data
